Pinnacle Financial Partners Inc Eli Lilly & CO Transaction History

Pinnacle Financial Partners Inc

$4.92 Billion
Q3 2024

A detailed history of Pinnacle Financial Partners Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 35,961 shares of LLY stock, worth $28.4 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

35,961

Previous 35,686 0.77%

Holding current value

$28.4 Million

Previous $32.3 Million 1.39%

% of portfolio

0.65%

Previous 0.69%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $212,338 - $264,005	275 Added 0.77%	35,961 $31.9 Million
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $3.97 Million - $4.98 Million	-5,474 Reduced 13.3%	35,686 $32.3 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $2.14 Million - $2.87 Million	3,620 Added 9.64%	41,160 $32 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $379,712 - $447,630	-723 Reduced 1.89%	37,540 $21.9 Million
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $1.3 Million - $1.79 Million	-2,988 Reduced 7.24%	38,263 $20.6 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $1.36 Million - $1.82 Million	-3,872 Reduced 8.58%	41,251 $19.3 Million
Q1 2023 Apr 26, 2023	BUY	$310.63 - $364.82 $63,368 - $74,423	204 Added 0.45%	45,123 $15.5 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $7,395 - $8,617	23 Added 0.05%	44,919 $16.4 Million
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $62,853 - $71,628	-212 Reduced 0.47%	44,896 $14.5 Million
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $351,757 - $413,014	1,262 Added 2.88%	45,108 $14.6 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $851,220 - $1.06 Million	-3,627 Reduced 7.64%	43,846 $12.6 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $70,602 - $87,618	314 Added 0.67%	47,473 $13.1 Million
Q3 2021 Oct 26, 2021	BUY	$221.6 - $272.71 $62,712 - $77,176	283 Added 0.6%	47,159 $10.9 Million
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $82,872 - $107,194	-459 Reduced 0.97%	46,876 $10.8 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $3.99 Million - $5.17 Million	-24,309 Reduced 33.93%	47,335 $8.84 Million
Q4 2020 Jan 13, 2021	SELL	$130.46 - $172.63 $264,051 - $349,403	-2,024 Reduced 2.75%	71,644 $12.1 Million
Q3 2020 Oct 27, 2020	BUY	$146.22 - $169.13 $249,597 - $288,704	1,707 Added 2.37%	73,668 $10.9 Million
Q2 2020 Jul 28, 2020	BUY	$136.42 - $164.18 $383,203 - $461,181	2,809 Added 4.06%	71,961 $11.8 Million
Q1 2020 Apr 16, 2020	BUY	$119.05 - $147.35 $1.35 Million - $1.68 Million	11,374 Added 19.69%	69,152 $9.59 Million
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $14,754 - $18,275	138 Added 0.24%	57,778 $7.59 Million
Q3 2019 Oct 25, 2019	BUY	$106.79 - $116.16 $641,167 - $697,424	6,004 Added 11.63%	57,640 $6.45 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $334,364 - $390,287	3,018 Added 6.21%	51,636 $5.72 Million
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $249,223 - $293,353	2,239 Added 4.83%	48,618 $6.31 Million
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $95,627 - $107,131	903 Added 1.99%	46,379 $5.37 Million
Q3 2018 Oct 31, 2018	BUY	$85.86 - $107.31 $48,596 - $60,737	566 Added 1.26%	45,476 $4.88 Million
Q2 2018 Jul 27, 2018	BUY	$75.7 - $86.88 $194,246 - $222,934	2,566 Added 6.06%	44,910 $3.83 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $37,105 - $43,800	500 Added 1.19%	42,344 $3.28 Million
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $390,116 - $418,444	4,761 Added 12.84%	41,844 $3.53 Million
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $2.86 Million - $3.17 Million	37,083	37,083 $3.17 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.

Account

Pinnacle Financial Partners Inc Eli Lilly & CO Transaction History